Search research articles
Contact Us
Filters
Showing results (21-30 of 186) with videos related to
Page
of 19
Sort By:
Experimental Hematology
|
June 14, 2002
Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation
Simon J Bubnic, Armand Keating
Current Opinion in Hematology
|
July 16, 2025
Mesenchymal stromal cells: an update
Olivia J Lee, Armand Keating
Stem Cells (Dayton, Ohio)
|
April 13, 2012
Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research
Darwin J Prockop, Armand Keating
Gerontology
|
September 18, 2008
Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review
Brent A Williams, Armand Keating
Expert Review of Anticancer Therapy
|
June 25, 2003
Advances in targeted therapy for chronic myeloid leukemia
Karen W L Yee, Armand Keating
Haematologica
|
March 2, 2013
When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes
Natividad Cuende, Concha Herrera, Armand Keating
Human Gene Therapy
|
February 4, 2011
Mesenchymal stromal cells for graft-versus-host disease
Jakub Tolar, Pierre Villeneuve, Armand Keating
Blood
|
January 26, 2011
How I treat relapsed and refractory Hodgkin lymphoma
John Kuruvilla, Armand Keating, Michael Crump
Current Opinion in Organ Transplantation
|
December 23, 2016
Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair
Agata Bartczak, Ian McGilvray, Armand Keating
Hematology (Amsterdam, Netherlands)
|
May 15, 2003
Acute promyelocytic leukemia: a case-based review
Vikas Gupta, Daniel Tabak, Armand Keating
Page
of 19
Search research articles
Search
Showing results (21-30 of 186) with videos related to
Sort By:
Page
of 19
Experimental Hematology
|
June 14, 2002
Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation
Simon J Bubnic, Armand Keating
Current Opinion in Hematology
|
July 16, 2025
Mesenchymal stromal cells: an update
Olivia J Lee, Armand Keating
Stem Cells (Dayton, Ohio)
|
April 13, 2012
Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research
Darwin J Prockop, Armand Keating
Gerontology
|
September 18, 2008
Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review
Brent A Williams, Armand Keating
Expert Review of Anticancer Therapy
|
June 25, 2003
Advances in targeted therapy for chronic myeloid leukemia
Karen W L Yee, Armand Keating
Haematologica
|
March 2, 2013
When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes
Natividad Cuende, Concha Herrera, Armand Keating
Human Gene Therapy
|
February 4, 2011
Mesenchymal stromal cells for graft-versus-host disease
Jakub Tolar, Pierre Villeneuve, Armand Keating
Blood
|
January 26, 2011
How I treat relapsed and refractory Hodgkin lymphoma
John Kuruvilla, Armand Keating, Michael Crump
Current Opinion in Organ Transplantation
|
December 23, 2016
Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair
Agata Bartczak, Ian McGilvray, Armand Keating
Hematology (Amsterdam, Netherlands)
|
May 15, 2003
Acute promyelocytic leukemia: a case-based review
Vikas Gupta, Daniel Tabak, Armand Keating
Page
of 19